A multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma patients.
Clinical Cancer Research.
Times cited: 13
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Times cited: 18